 Designed and validated to handle high potent molecules less than 1 μgm3 containment First commercial production batch has commenced HYDERABAD, India, Jan. 17, 2023 PRNewswire Sai Life Sciences, one of Indias fastest growing Contract Research, Development Manufacturing Organizations CRO-CDMO, today announced the opening of a new High-Potency API HPAPI manufacturing facility at its cGMP API... The post Sai Life Sciences opens new High-Potency API Manufacturing facility at its Bidar Campu... 